RT Journal Article
SR Electronic
T1 Doctors’ and Nurses’ Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.23.21259402
DO 10.1101/2021.06.23.21259402
A1 Emily Breza
A1 Fatima Cody Stanford
A1 Marcela Alsan
A1 Burak Alsan
A1 Abhijit Banerjee
A1 Arun G. Chandrasekhar
A1 Sarah Eichmeyer
A1 Traci Glushko
A1 Paul Goldsmith-Pinkham
A1 Kelly Holland
A1 Emily Hoppe
A1 Mohit Karnani
A1 Sarah Liegl
A1 Tristan Loisel
A1 Lucy Ogbu-Nwobodo
A1 Benjamin A. Olken
A1 Carlos Torres
A1 Pierre-Luc Vautrey
A1 Erica Warner
A1 Susan Wootton
A1 Esther Duflo
YR 2021
UL http://medrxiv.org/content/early/2021/07/02/2021.06.23.21259402.abstract
AB During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale Facebook ad campaign disseminating these messages. In the first level of randomization, we randomly divided the counties into two groups: high intensity and low intensity. In the second level, we randomly assigned zip codes to either treatment or control such that 75% of zip codes in high intensity counties received the treatment, while 25% of zip codes in low intensity counties received the treatment. In each treated zip code, we sent the ad to as many Facebook subscribers as possible (11,954,109 users received at least one ad at Thanksgiving and 23,302,290 users received at least one ad at Christmas). The first primary outcome was aggregate holiday travel, measured using mobile phone location data, available at the county level: we find that average distance travelled in high-intensity counties decreased by −0.993 percentage points (95% CI −1.616, −0.371, p-value 0.002) the three days before each holiday. The second primary outcome was COVID-19 infection at the zip-code level: COVID-19 infections recorded in the two-week period starting five days post-holiday declined by 3.5 percent (adjusted 95% CI [-6.2 percent, −0.7 percent], p-value 0.013) in intervention zip codes compared to control zip codes.One sentence summary In a large scale clustered randomized controlled trial, short messages recorded by health professionals before the winter holidays in the United States and sent as ads to social media users led to a significant reduction in holiday travel, and to a decrease in subsequent COVID-19 infection at the population level.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04644328Funding StatementSupported by the National Science Foundation under award number 2029880 (MA, ED). Supported by the Physician/Scientist Development Award (PSDA) granted by the Executive Committee on Research (ECOR) at MGH (FCS), NIH P30 DK040561(FCS), L30 DK118710 (FCS).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The design was approved by the institutional review board of the Massachusetts Institute of Technology (MIT) with Massachusetts General Hospital (MGH), Yale and Harvard ceding authority to MIT IRB. Messages were produced by the research team and approved to run (without modification) after going through Facebook internal policy review to ensure compliance with policies.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available by request from the authors.